HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Giovanni Battista Luciani Alessandro Mazzucco Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Luciani, G. B. Articles by Mazzucco, A. Search for Related Content PubMed PubMed Citation Articles by Luciani, G. B. Articles by Mazzucco, A.

J Thorac Cardiovasc Surg 2000;120:478-489
© 2000 The American Association for Thoracic Surgery

Surgery for Acquired Cardiovascular Disease

Predicting long-term functional results after myocardial revascularization in ischemic cardiomyopathy

From the Division of Cardiac Surgery, University of Verona, Verona, Italy.

Presented in part at the Seventy-second Meeting of the American Heart Association, Atlanta, Ga, 1999.

Address for reprints: Giovanni Battista Luciani, MD, Division of Cardiac Surgery, University of Verona, O. C. M. Piazzale Stefani 1, Verona, 37126, Italy (E-mail: luciani{at}netbusiness.it ).

Objective: The goal of the present study was to define the early and late functional results after revascularization in ischemic cardiomyopathy and to identify variables predictive of a favorable outcome.
Methods: A retrospective review of all consecutive patients with ischemic cardiomyopathy undergoing myocardial revascularization between January 1991 and June 1998 was undertaken. One hundred sixty-seven patients (140 men) aged 60 ± 8 years (range, 39-77 years) with angina (n = 107), congestive heart failure (n = 54), or silent ischemia (n = 6) were identified. One hundred six (63%) patients with angina were in Canadian Cardiovascular Society class III or IV, and 40 (24%) patients with congestive failure were in New York Heart Association class III or IV. The preoperative left ventricular ejection fraction averaged 0.28 ± 0.05 (range, 0.16-0.30). Thirteen (8%) patients required preoperative mechanical life support. A mean of 2.9 ± 0.9 grafts per patient were performed, with an average myocardial ischemia time of 53 ± 23 minutes and bypass time of 104 ± 31 minutes.
Results: There were 3 (1.7%) early deaths and 21 (13%) deaths during follow-up (2.7 ± 2.1 years; range, 0.3-7.8 years), producing a survival of 94% ± 2% and 75% ± 10% at 1 and 5 years, respectively. Despite a significant increase in left ventricular ejection fraction (0.28 ± 0.05 vs 0.38 ± 0.09, P = .0001), only 89 (54%) patients were symptom-free at follow-up. Freedom from recurrent angina was 98% ± 1% and 81% ± 8%, whereas freedom from congestive failure was 78% ± 11% and 47% ± 20% at 1 and 5 years, respectively. Follow-up New York Heart Association class in patients with congestive failure was improved (40/54 class III-IV vs 11/54 class III-IV, P = .0001). Multivariate analysis showed a lower ejection fraction (P = .01), preoperative congestive failure (P = .03), and a need for preoperative intra-aortic balloon pumping (P = .03) to be associated with a greater prevalence of recurrent congestive failure, whereas male sex (P = .01), preoperative angina (P = .04), use of the internal thoracic artery (P = .03), and higher number of grafts (P = .01) were associated with lower prevalence. Male sex (P = .06), higher number of grafts (P = .04), and shorter duration of myocardial ischemia (P = .04) were also predictive of improvement in New York Heart Association class at follow-up.
Conclusions: Despite satisfactory early and late survival, late functional outcome after myocardial revascularization in ischemic cardiomyopathy remains suboptimal because of recurrence or persistence of congestive failure. Selection of appropriate surgical candidates and extensive use of complete revascularization with the internal thoracic artery may substantially improve functional results.

This article has been cited by other articles:

				M. A. Soliman Hamad, M. E. S.H. Tan, A. H.M. van Straten, A. A.J. van Zundert, and J. P.A.M. Schonberger Long-Term Results of Coronary Artery Bypass Grafting in Patients With Left Ventricular Dysfunction Ann. Thorac. Surg., February 1, 2008; 85(2): 488 - 493. [Abstract] [Full Text] [PDF]

				H. Hegazy, A. Refaei, A. Assedique, S. Alsaif, M. Taha, M. Refaei, N. Elkum, H. Alomran, and Z. Al-Halees PET scan before CABG in diabetes The British Journal of Diabetes & Vascular Disease, January 1, 2007; 7(1): 32 - 37. [Abstract] [PDF]

				G. D. Buckberg Questions and answers about the STICH trial: A different perspective J. Thorac. Cardiovasc. Surg., August 1, 2005; 130(2): 245 - 249. [Full Text] [PDF]

				A. Yamaguchi, H. Adachi, K. Kawahito, S. Murata, and T. Ino Left Ventricular Reconstruction Benefits Patients With Dilated Ischemic Cardiomyopathy Ann. Thorac. Surg., February 1, 2005; 79(2): 456 - 461. [Abstract] [Full Text] [PDF]

				C. L. Athanasuleas, G. D. Buckberg, A. W.H. Stanley, W. Siler, V. Dor, M. Di Donato, L. Menicanti, S. Almeida de Oliveira, F. Beyersdorf, I. L. Kron, et al. Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation J. Am. Coll. Cardiol., October 6, 2004; 44(7): 1439 - 1445. [Abstract] [Full Text] [PDF]

				T. S. Maxey, T. B. Reece, P. I. Ellman, P. D. Butler, J. A. Kern, C. G. Tribble, and I. L. Kron Coronary artery bypass with ventricular restoration is superior to coronary artery bypass alone in patients with ischemic cardiomyopathy J. Thorac. Cardiovasc. Surg., February 1, 2004; 127(2): 428 - 434. [Abstract] [Full Text] [PDF]

				P. J. Shah, D. L. Hare, J. S. Raman, I. Gordon, R. K. Chan, J. D. Horowitz, A. Rosalion, and B. F. Buxton Survival after myocardial revascularization for ischemic cardiomyopathy: A prospective ten-year follow-up study J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1320 - 1327. [Abstract] [Full Text] [PDF]

				J. F. Gummert, A. Rahmel, J. Bucerius, J. Onnasch, N. Doll, T. Walther, V. Falk, and F. W. Mohr Mitral valve repair in patients with end stage cardiomyopathy: who benefits? Eur. J. Cardiothorac. Surg., June 1, 2003; 23(6): 1017 - 1022. [Abstract] [Full Text] [PDF]

				P E Antunes, J M F. de Oliveira, and M J Antunes Coronary surgery with non-cardioplegic methods in patients with advanced left ventricular dysfunction: immediate and long term results Heart, April 1, 2003; 89(4): 427 - 431. [Abstract] [Full Text] [PDF]

				G. D. Buckberg Congestive heart failure: Treat the disease, not the symptom--return to normalcy J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(90030): S41 - 49. [Full Text] [PDF]

				K. Toda, K. Mackenzie, M. R. Mehra, C. J. DiCorte, J. E. Davis, P. M. McFadden, J. L. Ochsner, C. White, and C. H. Van Meter Jr Revascularization in severe ventricular dysfunction (15% <= LVEF <= 30%): a comparison of bypass grafting and percutaneous intervention Ann. Thorac. Surg., December 1, 2002; 74(6): 2082 - 2087. [Abstract] [Full Text] [PDF]

				R. Lorusso, G. La Canna, C. Ceconi, V. Borghetti, P. Totaro, G. Parrinello, G. Coletti, and G. Minzioni Long-term results of coronary artery bypass grafting procedure in the presence of left ventricular dysfunction and hibernating myocardium Eur. J. Cardiothorac. Surg., November 1, 2001; 20(5): 937 - 948. [Abstract] [Full Text] [PDF]

				K. Minami Surgical Treatments for Endstage Heart Failure Due to Dilated Cardiomyopathy Asian Cardiovasc Thorac Ann, September 1, 2001; 9(3): 159 - 166. [Full Text] [PDF]

				G. D. Buckberg Congestive heart failure: Treat the disease, not the symptom--Return to normalcy J. Thorac. Cardiovasc. Surg., April 1, 2001; 121(4): 628 - 637. [Full Text] [PDF]

				Late Functional Outcome After CABG in Ischemic Cardiomyopathy Remains Poor Journal Watch Cardiology, December 1, 2000; 2000(1201): 8 - 8. [Full Text]